Novel plasma biomarker surrogating cerebral amyloid deposition
Authors:
Open Access
- 1 January 2014
- journal article
- research article
- Published by Japan Academy in Proceedings of the Japan Academy, Series B
- Vol. 90 (9) , 353-364
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 38 references indexed in Scilit:
- The efficacy of plasma biomarkers in early diagnosis of Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2013
- The future of blood‐based biomarkers for Alzheimer's diseaseAlzheimer's & Dementia, 2013
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyThe Lancet Neurology, 2013
- Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s diseaseJournal of Neural Transmission, 2012
- Amyloid vs FDG-PET in the differential diagnosis of AD and FTLDNeurology, 2011
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderlyAnnals of Neurology, 2009
- -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's diseaseBrain, 2007
- Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer DiseaseArchives of Neurology, 2000
- Alzheimer Neuropathologic Alterations in Aged Cognitively Normal SubjectsJournal of Neuropathology & Experimental Neurology, 1999